kras mutation and glutathion glynac Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of G13D: Cell Reports KRAS-Targeted Therapy Doubles as Component
KRAS Targeted Therapy Doubles as Component of Immunotherapy NCI Mutant KRas Induced Mitochondrial Oxidative Stress in Acinar Cells Upregulates EGFR Signaling to Drive Formation of Pancreatic Precancerous Lesions ScienceDirect Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega KRAS G12 mutant alleles differentially control glutamine metabolism via FOXO1 bioRxiv The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link The Metabolic Landscape of RAS Driven Cancers from biology to therapy PMC
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1





